Elinzanetant | m-entrepreneurship.com

Product Name :
Elinzanetant

Search keywords :
Neurokinin B

drugId :
null

Target Vo:
Neurokinin 1 receptor

Target Vo Short Name :
NK1R

Moa_Name:
Neurokinin 3 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Bayer AG

Active Indication_Name:
HR-positive breast cancer

In Active Indication_Name:
Opioid-Related Disorders

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
His Tag Antibody (HRP) (YA877) MedChemExpress
ALDH1A1 Rabbit mAb Biological Activity
Ku80 Antibody: Ku80 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to Ku80. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts